Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — November 2025

Genmab — November 2025

Planlagt Fastgjort Låst Flyttet Genmab
176 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • R Offline
    R Offline
    Raun
    wrote on sidst redigeret af
    #27

    Schyyyyy.... Opjusteringer er noget være lort for kursen

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #28

      Ser ud til at markedet regner med en solid opjustering. Aktien falder 2,4% pt.

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gdn55
        wrote on sidst redigeret af
        #29

        Novo nede med ca. 3,5 Ambu 18 Zeeland 3,5 Genmab 2,5.

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #30

          Genmab A/S is set to announce its Q3 2025 earnings on November 6, 2025, with analysts expecting earnings of $0.47 per share and revenue of $975.4 million https://www.marketbeat.com/instant-alerts/genmab-as-gmab-expected-to-announce-quarterly-earnings-on-thursday-2025-10-30/

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #31

            Genmab AS (GMAB, Financial) is set to release its Q3 2025 earnings on Nov 6, 2025. The consensus estimate for Q3 2025 revenue is $986.99 million, and the earnings are expected to come in at $0.46 per share. https://www.gurufocus.com/news/3185679/genmab-as-gmab-q3-2025-earnings-report-preview-what-to-look-for

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #32

              seekingalpha: Genmab (GMAB) is scheduled to announce Q3 earnings results on Thursday, November 6th, before market open. The consensus EPS Estimate is $0.45 and the consensus revenue estimate is $983.65M.

              1 Reply Last reply
              0
              • P Offline
                P Offline
                Pensionisten
                wrote on sidst redigeret af
                #33

                Regnskab vel først efter markedet i DK er lukket - oplyst efter kl. 17.00 - som sædvanligt.

                1 Reply Last reply
                0
                • R Offline
                  R Offline
                  Raun
                  wrote on sidst redigeret af
                  #34

                  Flot dag i US - et luk lige i underkanten af 1900 under pæn omsætning

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bikube
                    wrote on sidst redigeret af
                    #35

                    Da jeg så det, måtte jeg lige taste en gang mere på regneren - den siger 1897,4.

                    1 Reply Last reply
                    0
                    • T Offline
                      T Offline
                      transalp
                      wrote on sidst redigeret af
                      #36

                      Go morgen.. 🙂

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #37

                        so Novo confirmed yesterday they also submitted an appliction for approval of denecimig / Mim8 to EMA in september

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #38

                          From lab coat to Lifestar: Jan van de Winkel shares his success story
                          Before Genmab's co-founder and CEO collects his Lifetime Achievement Award this November, BioXconomy caught up with him for an exclusive chat about his remarkable journey. https://www.bioxconomy.com/partnering/from-lab-coat-to-lifestar-jan-van-de-winkel-shares-his-success-story

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Raun
                            wrote on sidst redigeret af
                            #39

                            Nøj, hvor er DK træls ved aktien for tiden. - Efter det store fald ovenpå Merus usikkerheden, så må aktien på ingen måder komme over 1900 og hvis kursen nærmer sig, så bliver den stille og roligt pillet ned igen - det er godt nok set nogle gange nu

                            1 Reply Last reply
                            0
                            • StockBullS Offline
                              StockBullS Offline
                              StockBull
                              wrote on sidst redigeret af
                              #40

                              Ligner en normal retracement og ser ud til bunden i 1818 holder, Retracements på daggrafen tager tid. Target 2150 slut November

                              1 Reply Last reply
                              0
                              • R Offline
                                R Offline
                                Raun
                                wrote on sidst redigeret af
                                #41

                                Håber du får ret @Stockbull

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #42

                                  New Ph3 trial: Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy (RAINFOL-04) https://clinicaltrials.gov/study/NCT07225270

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #43

                                    Genmab Announces Financial Results for the Nine Months of 2025 https://proinvestor.com/investornyt/1380034/genmab-announces-financial-results-for-the-nine-months-of-2025

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Stroka
                                      wrote on sidst redigeret af
                                      #44

                                      "Operating profit was $1,007 million in the first nine months of 2025 compared to $662 million in the first nine months of 2024".

                                      1 Reply Last reply
                                      0
                                      • V Offline
                                        V Offline
                                        Vitus
                                        wrote on sidst redigeret af
                                        #45

                                        Så falder Genmab i USA -:(

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #46

                                          GEN1042 lagt halvt i graven

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper